In adults with T2D and heart failure with preserved ejection fraction (HFpEF) whose HbA1c remains above target despite dual therapy with metformin and SGLT2i, triple therapy by adding GLP-1 RA is safe and SHOULD BE CONSIDERED to improve glycemic control. This evidence concerns the gene GLP1R and heart failure.